Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x ULN = U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L (x ULN); for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x ULN = U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransaminase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate (SGPT) (alanine aminotransferase [ALT]) =< U/L (for the purpose of this study, the upper limit of normal [ULN] for SGPT is U/L) Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) < . x upper limit of normal (ULN) for age; for the purpose of this study, the ULN for ALT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L ( x ULN) (for the purpose of this study, the ULN for SGPT is U/L) Patients with solid tumors: serum glutamic pyruvic transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamic pyruvic transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamic pyruvic transaminase (SGPT) (alanine aminotransferase [ALT]) =< . x ULN (for the purpose of this study, the ULN for SGPT is U/L) Alanine aminotransferase (ALT) serum glutamic pyruvic transaminase (SGPT) =< U/L; for the purpose of this study, the ULN for ALT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x ULN = units per liter (U/L); for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< . x ULN (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x upper limit of normal (ULN) = U/l; for the purpose of this study, the ULN for SGPT is U/l Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamic pyruvic transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L PART GROUP INCLUSION CRITERIA: Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L PART GROUP A INCLUSION CRITERIA: SGPT (ALT) =< U/L; for the purpose of this study, the ULN for SGPT is U/L PART GROUP INCLUSION CRITERIA: Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; (for the purpose of this study, the ULN for SGPT is U/L) within days prior to enrollment Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) less than or equal to U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT)/alanine aminotransferase measurement (ALT) ? x the ULN; for the purpose of this study, the ULN for SGPT is U/L. Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamic pyruvic transaminase (SGPT) (alanine aminotransferase [ALT]) =< x ULN for age; for the purpose of this study, the ULN for ALT will be U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L (for the purpose of this study, the ULN for SGPT is U/L) Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Patients on Part A and Part B: serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Patients on Part C with ALL: SGPT (ALT) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< . x ULN for age (=< U/L); for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L and Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) < . x upper limit of normal (ULN) for age; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum Glutamic Pyruvate Transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L; for the purpose of this study, the ULN for SGPT is U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< units per liter (U/L); for the purpose of this study, the ULN for SGPT is U/L Serum glutamic pyruvic transaminase (SGPT) (alanine aminotransaminase [ALT]) =< units per liter (U/L); for the purpose of this study, the ULN for SGPT is U/L GENERAL INCLUSION CRITERIA FOR SUBPROTOCOLS: serum glutamate pyruvate transaminase (SGPT) (alanine transferase [ALT]) =< U/L (for the purpose of this study, the ULN for SGPT is U/L)